Synonyms: BRL-2039 | BRL2039 | floxacillin
flucloxacillin is an approved drug (UK)
Compound class:
Synthetic organic
Comment: Flucloxacillin is a narrow-spectrum, semisynthetic penicillin (β-lactam) antibacterial. It is β-lactamase stable.
|
|
No information available. |
Summary of Clinical Use ![]() |
Flucloxacillin is not approved by the EMA or FDA. Generic flucloxacillin is authorised for use in the UK and other countries. UK approval allows flucloxacillin (oral, injection or infusion) to treat infections by penicillinase producing staphylococci and other sensitive Gram-positive organisms, such as osteomyelitis [1-2] and endocarditis. It can also be used prophylactically during major cardiothoracic and orthopaedic surgical procedures if appropriate. Flucloxacillin is ineffective against methicillin-resistant Staphylococcus aureus (MRSA). |
External links ![]() |
For extended ADME data see the following: Electronic Medicines Compendium (eMC) |